Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Aster DM Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹574.85Overvalued by 16.45%vs CMP ₹688.00

P/E (98.7) × ROE (8.3%) × BV (₹87.50) × DY (0.73%)

₹191.78Overvalued by 72.13%vs CMP ₹688.00
MoS: -258.7% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹519.7123%Over (-24.5%)
Graham NumberEarnings₹111.9016%Over (-83.7%)
Earnings PowerEarnings₹161.6611%Over (-76.5%)
DCFCash Flow₹28.0814%Over (-95.9%)
Net Asset ValueAssets₹87.717%Over (-87.3%)
EV/EBITDAEnterprise₹153.649%Over (-77.7%)
Earnings YieldEarnings₹63.607%Over (-90.8%)
ROCE CapitalReturns₹62.577%Over (-90.9%)
Revenue MultipleRevenue₹80.065%Over (-88.4%)
Consensus (9 models)₹191.78100%Overvalued
Key Drivers: Wide model spread (₹28–₹520) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -9.6%

*Investments are subject to market risks

Analyst Summary

Aster DM Healthcare Ltd operates in the Hospitals & Medical Services segment, NSE: ASTERDM | BSE: 540975, current market price is ₹688.00, market cap is 35,559 Cr.. At a glance, stock P/E is 98.7, ROE is 8.26 %, ROCE is 10.7 %, book value is 87.5, dividend yield is 0.73 %. The latest intrinsic value estimate is ₹191.78, around 72.1% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹4,138 Cr versus the prior period change of 11.9%, while latest net profit is about ₹5,408 Cr with a prior-period change of 2,450.9%. The 52-week range shown on this page is 732/450, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisAster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L8…

This summary is generated from the stock page data available for Aster DM Healthcare Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

53
Aster DM Healthcare Ltd scores 53/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health58/100 · Moderate
ROCE 10.7% AverageROE 8.3% AverageD/E 0.56 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -3.20% (6mo) SellingDII holding up 1.54% MF buyingPromoter holding at 40.4% Stable
Earnings Quality60/100 · Moderate
OPM stable around 17% SteadyWorking capital: -32 days (improving) Efficient
Quarterly Momentum50/100 · Moderate
Revenue (4Q): +8% YoY GrowingProfit (4Q): -93% YoY Declining
Industry Rank40/100 · Moderate
P/E 98.7 vs industry 75.2 In-lineROCE 10.7% vs industry 14.7% Average3Y sales CAGR: -26% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:38 am

Market Cap 35,559 Cr.
Current Price 688
Intrinsic Value₹191.78
High / Low 732/450
Stock P/E98.7
Book Value 87.5
Dividend Yield0.73 %
ROCE10.7 %
ROE8.26 %
Face Value 10.0
PEG Ratio-10.29

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Aster DM Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Aster DM Healthcare Ltd 35,559 Cr. 688 732/45098.7 87.50.73 %10.7 %8.26 % 10.0
Dr Lal Pathlabs Ltd 22,178 Cr. 1,324 1,771/1,17640.4 1430.91 %28.9 %24.3 % 10.0
Fortis Healthcare Ltd 60,019 Cr. 795 1,105/52159.6 1250.13 %12.0 %10.1 % 10.0
Metropolis Healthcare Ltd 8,796 Cr. 424 566/32950.3 69.10.24 %14.7 %11.5 % 2.00
Healthcare Global Enterprises Ltd 7,990 Cr. 535 800/498294 61.70.00 %8.56 %5.14 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Aster DM Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 3,1928078419299559741,0021,0861,0501,0001,0781,1971,186
Expenses 2,743687722787805817841869864818876961983
Operating Profit 449120119142149156161217186182202236202
OPM % 14%15%14%15%16%16%16%20%18%18%19%20%17%
Other Income 10149-17-64153-405,12035952928-0
Interest 87252530253029313132313131
Depreciation 198545154575860626264636668
Profit before tax 17319026-7220285,19115910291136167103
Tax % 8%4%24%120%5%108%1%33%37%6%31%27%43%
Net Profit 15918320-15209-25,15210664869412159
EPS in Rs 2.793.420.10-0.623.59-0.48103.001.941.141.581.652.121.01

Last Updated: February 6, 2026, 3:46 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 20, 2026, 4:00 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2,8713,8765,2505,9316,7217,9638,6528,60810,2532,9943,6994,1384,461
Expenses 2,4213,3704,8055,5826,0896,8867,1877,5068,7202,5473,1243,3843,639
Operating Profit 4515064453496321,0771,4651,1031,533447575754822
OPM % 16%13%8%6%9%14%17%13%15%15%16%18%18%
Other Income 192325453177-155-1585351353325,16961
Interest 487918937120420539133430796119133125
Depreciation 111144243322298306586618641192220249261
Profit before tax 310306381083084103302056375112685,542497
Tax % 9%11%78%10%8%10%5%13%6%7%21%2%
Net Profit 2842728982823673151786014752125,408359
EPS in Rs 4.697.000.202.525.326.595.542.9610.538.512.59107.666.36
Dividend Payout % 35%-0%-0%-0%-0%-0%-0%-0%-0%-0%4,637%5%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-4.23%-97.06%1125.00%187.76%30.14%-14.17%-43.49%237.64%-20.97%-55.37%2450.94%
Change in YoY Net Profit Growth (%)0.00%-92.83%1222.06%-937.24%-157.61%-44.31%-29.32%281.13%-258.61%-34.40%2506.31%

Aster DM Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:1%
5 Years:-14%
3 Years:-26%
TTM:9%
Compounded Profit Growth
10 Years:1%
5 Years:-7%
3 Years:-17%
TTM:82%
Stock Price CAGR
10 Years:%
5 Years:38%
3 Years:38%
1 Year:56%
Return on Equity
10 Years:8%
5 Years:8%
3 Years:7%
Last Year:8%

Last Updated: September 4, 2025, 11:55 pm

Balance Sheet

Last Updated: December 4, 2025, 12:59 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 375389403403505505497497500500500500518
Reserves 5361,096171,4722,3272,7092,7752,8753,0803,5743,6862,5544,015
Borrowings 8861,0913,3212,7582,3522,7885,6054,8045,2826,0751,7582,3922,089
Other Liabilities 1,0971,8342,0032,1712,2962,9263,5283,4443,6614,68712,0391,1541,186
Total Liabilities 2,8944,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6007,808
Fixed Assets 1,0872,2372,5073,5203,7384,2897,1246,7497,0099,0523,1753,9204,024
CWIP 357197358290402550736934998279170293401
Investments 733932382234634580172451,184
Other Assets 1,4421,9722,8392,9623,3024,0674,5113,8744,4705,42514,6202,1422,199
Total Assets 2,8944,4095,7436,8047,4798,92812,40511,62012,52114,83617,9836,6007,808

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 2362033615376011,2231,5691,3141,834158425
Cash from Investing Activity + -439-775-1,136-522-702-658-333-563-951-8786,015
Cash from Financing Activity + 20357865446134-675-1,116-686-8171,053-6,358
Net Cash Flow -15-1226133-110120656633282
Free Cash Flow -176-536-56523647151,183770995-60170
CFO/OP 51%53%116%93%61%88%143%89%424%40%72%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-435.00505.00442.00347.00630.00-1.00-4.00-3.00-4.00441.00574.00752.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 86839379849310086722852323
Inventory Days 7193921021111101381221296124436
Days Payable 1761781871511501533032902671,400183166
Cash Conversion Cycle -18-2-1304550-65-83-66-503-116-107
Working Capital Days 61696865928855-21272-32
ROCE %18%14%6%1%7%13%12%6%10%3%4%11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 41.88%41.88%41.88%41.88%41.88%41.88%41.88%41.88%41.89%40.39%40.39%40.39%
FIIs 38.63%38.82%40.22%41.00%33.48%27.08%23.86%22.62%21.66%19.64%18.72%18.46%
DIIs 8.93%8.62%7.64%7.15%13.70%16.35%20.91%22.91%24.58%25.28%26.32%26.12%
Public 10.12%10.26%9.85%9.61%10.59%14.38%13.05%12.30%11.60%14.45%14.33%14.80%
Others 0.43%0.42%0.41%0.37%0.35%0.32%0.30%0.28%0.26%0.25%0.23%0.23%
No. of Shareholders 82,12971,37967,67367,33180,9312,06,6601,74,1711,59,0381,54,0141,48,1391,47,3041,46,998

Shareholding Pattern Chart

No. of Shareholders

Aster DM Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Small Cap Fund 23,927,134 3.58 1321.14N/AN/AN/A
Kotak Small Cap Fund 11,757,234 3.97 649.18N/AN/AN/A
Quant Small Cap Fund 11,305,160 2.28 624.211,758,4852025-12-08 07:20:44542.89%
Nippon India Small Cap Fund 9,522,707 0.8 525.8N/AN/AN/A
SBI Contra Fund 9,199,605 1.04 507.96N/AN/AN/A
Kotak Midcap Fund 6,423,124 0.6 354.656,137,3652026-01-26 00:42:094.66%
Franklin India Small Cap Fund 4,675,704 2.02 258.175,618,1342025-12-15 01:26:06-16.77%
HDFC Childrens Fund 3,759,174 2 207.56N/AN/AN/A
HSBC Small Cap Fund 3,574,000 1.31 197.34N/AN/AN/A
Franklin India Mid Cap Fund 2,407,002 1.09 132.9N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 107.982.608.5410.582.97
Diluted EPS (Rs.) 107.852.608.5310.572.97
Cash EPS (Rs.) 113.628.8725.1224.9615.93
Book Value[Excl.RevalReserv]/Share (Rs.) 68.63100.7089.8190.1577.14
Book Value[Incl.RevalReserv]/Share (Rs.) 68.63100.7089.8190.1577.14
Revenue From Operations / Share (Rs.) 82.8574.05238.89206.21173.19
PBDIT / Share (Rs.) 18.2712.0732.9030.8522.39
PBIT / Share (Rs.) 13.297.6617.2817.979.96
PBT / Share (Rs.) 9.815.4610.6912.804.05
Net Profit / Share (Rs.) 108.644.469.4912.083.51
NP After MI And SOA / Share (Rs.) 107.662.598.5110.582.97
PBDIT Margin (%) 22.0516.2913.7714.9612.92
PBIT Margin (%) 16.0410.347.238.715.75
PBT Margin (%) 11.837.364.476.202.34
Net Profit Margin (%) 131.136.023.975.852.02
NP After MI And SOA Margin (%) 129.943.493.565.121.71
Return on Networth / Equity (%) 156.872.8310.4313.304.38
Return on Capital Employeed (%) 11.595.718.449.935.86
Return On Assets (%) 81.400.712.854.191.26
Long Term Debt / Equity (X) 0.140.090.320.370.52
Total Debt / Equity (X) 0.180.140.560.550.56
Asset Turnover Ratio (%) 0.330.220.180.140.09
Current Ratio (X) 2.161.251.061.151.14
Quick Ratio (X) 2.061.250.770.860.86
Inventory Turnover Ratio (X) 40.800.000.000.000.00
Dividend Payout Ratio (NP) (%) 114.800.000.000.000.00
Dividend Payout Ratio (CP) (%) 109.730.000.000.000.00
Earning Retention Ratio (%) -14.800.000.000.000.00
Cash Earning Retention Ratio (%) -9.730.000.000.000.00
Interest Coverage Ratio (X) 7.375.464.995.973.79
Interest Coverage Ratio (Post Tax) (X) 4.282.962.443.341.59
Enterprise Value (Cr.) 23702.2921464.8514334.7212129.548918.86
EV / Net Operating Revenue (X) 5.735.801.201.181.04
EV / EBITDA (X) 25.9735.618.727.918.02
MarketCap / Net Operating Revenue (X) 5.855.531.010.950.79
Retention Ratios (%) -14.800.000.000.000.00
Price / BV (X) 7.064.482.962.482.02
Price / Net Operating Revenue (X) 5.855.531.010.950.79
EarningsYield 0.220.010.030.050.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Aster DM Healthcare Ltd. is a Public Limited Listed company incorporated on 18/01/2008 and has its registered office in the State of Kerala, India. Company's Corporate Identification Number(CIN) is L85110KA2008PLC147259 and registration number is 021703. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 2320.48 Cr. and Equity Capital is Rs. 499.52 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesAwfis, 2nd Floor, Renaissance Centra, 27 & 27/1, Mission Road, Bengaluru Kerala 560027Contact not found
Management
NamePosition Held
Dr. Azad MoopenFounder Chairman & Mng. Director
Ms. Alisha MoopenDeputy Managing Director
Mr. Daniel Robert MintzNon Executive Director
Mr. T J WilsonNon Executive Director
Mr. Shamsudheen Bin Mohideen Mammu HajiNon Executive Director
Dr. Zeba Azad MoopenNon Executive Director
Mr. Anoop MoopenNon Executive Director
Ms. Purana Housdurgamvijaya DeeptiIndependent Director
Mr. Chenayappillil John GeorgeIndependent Director
Mr. Maniedath Madhavan NambiarIndependent Director
Mr. Sunil Theckath VasudevanIndependent Director
Dr. James MathewIndependent Director
Mr. Emmanuel David GootamIndependent Director

FAQ

What is the intrinsic value of Aster DM Healthcare Ltd and is it undervalued?

As of 22 April 2026, Aster DM Healthcare Ltd's intrinsic value is ₹191.78, which is 72.12% lower than the current market price of ₹688.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (8.26 %), book value (₹87.5), dividend yield (0.73 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Aster DM Healthcare Ltd?

Aster DM Healthcare Ltd is trading at ₹688.00 as of 22 April 2026, with a FY2026-2027 high of ₹732 and low of ₹450. The stock is currently near its 52-week high. Market cap stands at ₹35,559 Cr..

How does Aster DM Healthcare Ltd's P/E ratio compare to its industry?

Aster DM Healthcare Ltd has a P/E ratio of 98.7, which is above the industry average of 75.17. The premium over industry average may reflect growth expectations or speculative interest.

Is Aster DM Healthcare Ltd financially healthy?

Key indicators for Aster DM Healthcare Ltd: ROCE of 10.7 % is moderate. Dividend yield is 0.73 %.

Is Aster DM Healthcare Ltd profitable and how is the profit trend?

Aster DM Healthcare Ltd reported a net profit of ₹5,408 Cr in Mar 2025 on revenue of ₹4,138 Cr. Compared to ₹601 Cr in Mar 2022, the net profit shows an improving trend.

Does Aster DM Healthcare Ltd pay dividends?

Aster DM Healthcare Ltd has a dividend yield of 0.73 % at the current price of ₹688.00. The company pays dividends, though the yield is modest.

Last Updated: April 2, 2026, 2:38 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 540975 | NSE: ASTERDM
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Aster DM Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports